Prostate Cell News Volume 12.25 | Jul 9 2021

    0
    31







    2021-07-09 | PCN 12.25


    Prostate Cell News by STEMCELL Technologies
    Vol. 12.25 – 9 July, 2021
    TOP STORY

    EZH2-Induced Lysine K362 Methylation Enhances TMPRSS2-ERG Oncogenic Activity in Prostate Cancer

    In both ERG positive VCaP cells and ERG/PTEN mice, PTEN loss resulted in AKT activation and enhancer of zest homolog 2 (EZH2) phosphorylation at serine 21 that favored ERG methylation.
    [Nature Communications]

    Full Article

    Virtual Conference Exhibition: Organoids
    PUBLICATIONSRanked by the impact factor of the journal

    Multiplexed Functional Genomic Analysis of 5′ Untranslated Region Mutations across the Spectrum of Prostate Cancer

    The authors developed a high-throughput multi-layer functional genomics method called Pooled full-length UTR Multiplex Assay on Gene Expression to quantify the molecular consequences of somatic 5’ UTR mutations in human prostate cancer.
    [Nature Communications]

    Full Article

    FAM64A Is an Androgen Receptor-Regulated Feedback Tumor Promoter in Prostate Cancer

    Researchers reported that Family With Sequence Similarity 64 Member A (FAM64A) was up-regulated and positively associated with poor prognosis of patients with prostate cancer (PCa). Knockdown of FAM64A significantly suppressed the proliferation, migration, invasion, and cell cycle of PCa cells in vitro.
    [Cell Death & Disease]

    Full Article

    Lipophagy and Prostate Cancer: Association with Disease Aggressiveness and Proximity to Periprostatic Adipose Tissue

    Investigators explored markers of autophagy and lipophagy in human prostate cancer tissues in correlation with factors of aggressiveness, and they evaluated the influence of periprostatic adipose tissue adipocytes on autophagy and lipophagy.
    [Journal of Pathology]

    AbstractFull Article

    Lactoferrin-Bearing Gold Nanocages for Gene Delivery in Prostate Cancer Cells In Vitro

    Scientists investigated whether the conjugation of gold nanocages with cancer-targeting ligand lactoferrin, polyethylene glycol, and polyethylenimine could lead to enhanced transfection efficiency on prostate cancer cells in vitro, without assistance of external stimulation.
    [International Journal of Nanomedicine]

    Full ArticleGraphical Abstract

    rAAV-Based and Intraprostatically Delivered miR-34a Therapeutics for Efficient Inhibition of Prostate Cancer Progression

    The authors found that miR-34a overexpression significantly inhibited the cell cycle, viability, and migration of prostate cancer cells by targeting its downstream genes.
    [Gene Therapy]

    Abstract

    High Expression of miR-17-5p in Tumor Epithelium Is a Predictor for Poor Prognosis for Prostate Cancer Patients

    In vitro analyses confirmed an association between overexpression of miR-17-5p and proliferation, migration and invasion in prostate cancer cell lines.
    [Scientific Reports]

    Full Article

    MiR-223-3p Targets FOXO3a to Inhibit Radiosensitivity in Prostate Cancer by Activating Glycolysis

    Researchers investigated the role of miR-223-3p in promoting radiotherapy resistance of prostate cancer cells by activating glycolysis.
    [Life Sciences]

    Abstract

    Inhibition of circ_0081234 Reduces Prostate Cancer Tumor Growth and Metastasis via miR-1/MAP3K1 Axis

    Circular RNAs (circRNAs) are crucial regulators in tumor occurrence and progression, and circRNAs are enriched and stable in exosomes. Investigators explored the role and potential mechanism of cancer-derived exosomal circ_0081234 in prostate cancer.
    [Journal of Gene Medicine]

    Abstract

    Implication of β2-Adrenergic Receptor and miR-196a Correlation in Neurite Outgrowth of LNCaP Prostate Cancer Cells

    Scientists investigated whether miR-196a played a role in the regulation of the β2-adrenergic receptor in the LNCaP prostate cancer cell line.
    [PLoS One]

    Full Article

    How to prioritize and manage your research projects
    REVIEWS

    The Potential of CAR T Cell Therapy for Prostate Cancer

    CAR T cell therapy has the potential to be combined with other treatment modalities, such as androgen deprivation therapy, radiotherapy, or chemotherapy, and could be applied as focal CAR T cell therapy for prostate cancer.
    [Nature Reviews Urology]

    Abstract

    INDUSTRY AND POLICY NEWS

    CLS and University Hospital Magdeburg Begin Study of MRI-Ultrasound, Fusion-Guided Focal Laser Ablation Treatments of Prostate Cancer

    Clinical Laserthermia Systems AB (CLS) announced that its collaboration with Otto-von-Guericke-University Magdeburg, Medical faculty has obtained approval from the ethics committee, and from the responsible Competent Authority, in Germany. CLS and the Magdeburg medical team will now proceed with Investigator Initiated Trial regarding MRI-Ultrasound, fusion-guided focal laser ablation treatment of prostate cancer.
    [Clinical Laserthermia Systems AB]

    Press Release

    Clean Interim Safety Review of RhoVac’s Clinical Phase IIb Study in Prostate Cancer

    RhoVac AB announced that its Safety Monitoring Committee has conducted a planned interim safety review of its clinical Phase IIb trial in prostate cancer, known as BRaVac.
    [RhoVac AB]

    Press Release

    FEATURED EVENT

    Till & McCulloch Meeting 2021

    November 15 – 17, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Prostate Cancer

    Augusta University – Augusta, Georgia, United States

    Lab Aide – Prostate Cancer

    Fred Hutchinson Cancer Research Center – Seattle, Washington, United States

    Epidemiologist – Prostate Disease Research

    Henry M Jackson Foundation for the Advancement of Military Medicine – Bethesda, Maryland, United States

    Senior Medical Science Liaison – Precision Oncology

    Exact Sciences – Indianapolis, Indiana, United States

    Research Fellow – Molecular Pharmacology & Experimental Therapeutics

    Mayo Clinic Health System – Rochester, Minnesota, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter